rs2229812

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000092.5(COL4A4):​c.3684G>A​(p.Lys1228Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.444 in 1,613,548 control chromosomes in the GnomAD database, including 161,616 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 16881 hom., cov: 33)
Exomes 𝑓: 0.44 ( 144735 hom. )

Consequence

COL4A4
NM_000092.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.447

Publications

24 publications found
Variant links:
Genes affected
COL4A4 (HGNC:2206): (collagen type IV alpha 4 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3' UTR. [provided by RefSeq, Jul 2008]
COL4A4 Gene-Disease associations (from GenCC):
  • autosomal recessive Alport syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Myriad Women’s Health, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Alport syndrome
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • hematuria, benign familial, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • autosomal dominant Alport syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 2-227032170-C-T is Benign according to our data. Variant chr2-227032170-C-T is described in ClinVar as Benign. ClinVar VariationId is 255032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.447 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.547 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000092.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A4
NM_000092.5
MANE Select
c.3684G>Ap.Lys1228Lys
synonymous
Exon 39 of 48NP_000083.3P53420

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A4
ENST00000396625.5
TSL:5 MANE Select
c.3684G>Ap.Lys1228Lys
synonymous
Exon 39 of 48ENSP00000379866.3P53420

Frequencies

GnomAD3 genomes
AF:
0.468
AC:
71072
AN:
152016
Hom.:
16850
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.530
Gnomad AMI
AF:
0.404
Gnomad AMR
AF:
0.468
Gnomad ASJ
AF:
0.500
Gnomad EAS
AF:
0.388
Gnomad SAS
AF:
0.565
Gnomad FIN
AF:
0.493
Gnomad MID
AF:
0.413
Gnomad NFE
AF:
0.425
Gnomad OTH
AF:
0.436
GnomAD2 exomes
AF:
0.474
AC:
118173
AN:
249372
AF XY:
0.472
show subpopulations
Gnomad AFR exome
AF:
0.536
Gnomad AMR exome
AF:
0.534
Gnomad ASJ exome
AF:
0.514
Gnomad EAS exome
AF:
0.400
Gnomad FIN exome
AF:
0.499
Gnomad NFE exome
AF:
0.426
Gnomad OTH exome
AF:
0.456
GnomAD4 exome
AF:
0.442
AC:
645697
AN:
1461414
Hom.:
144735
Cov.:
55
AF XY:
0.444
AC XY:
322713
AN XY:
727026
show subpopulations
African (AFR)
AF:
0.529
AC:
17703
AN:
33474
American (AMR)
AF:
0.528
AC:
23627
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.522
AC:
13639
AN:
26132
East Asian (EAS)
AF:
0.403
AC:
16017
AN:
39696
South Asian (SAS)
AF:
0.569
AC:
49103
AN:
86244
European-Finnish (FIN)
AF:
0.499
AC:
26641
AN:
53406
Middle Eastern (MID)
AF:
0.398
AC:
2296
AN:
5768
European-Non Finnish (NFE)
AF:
0.423
AC:
469797
AN:
1111596
Other (OTH)
AF:
0.445
AC:
26874
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
21511
43021
64532
86042
107553
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14556
29112
43668
58224
72780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.468
AC:
71147
AN:
152134
Hom.:
16881
Cov.:
33
AF XY:
0.469
AC XY:
34895
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.531
AC:
22021
AN:
41508
American (AMR)
AF:
0.469
AC:
7168
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1734
AN:
3470
East Asian (EAS)
AF:
0.388
AC:
2007
AN:
5172
South Asian (SAS)
AF:
0.565
AC:
2724
AN:
4822
European-Finnish (FIN)
AF:
0.493
AC:
5222
AN:
10592
Middle Eastern (MID)
AF:
0.403
AC:
117
AN:
290
European-Non Finnish (NFE)
AF:
0.425
AC:
28876
AN:
67970
Other (OTH)
AF:
0.430
AC:
910
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1905
3810
5714
7619
9524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.452
Hom.:
8992
Bravo
AF:
0.469
Asia WGS
AF:
0.482
AC:
1679
AN:
3478
EpiCase
AF:
0.403
EpiControl
AF:
0.410

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
3
not provided (3)
-
-
2
Alport syndrome (2)
-
-
1
Autosomal recessive Alport syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.37
DANN
Benign
0.45
PhyloP100
-0.45
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229812; hg19: chr2-227896886; COSMIC: COSV61632591; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.